Modeling quantifies in vivo neutralization, Fc-mediated killing, and resistance in human clinical trials of five anti-HIV broadly neutralizing antibodies.
Saved in:
| Title: | Modeling quantifies in vivo neutralization, Fc-mediated killing, and resistance in human clinical trials of five anti-HIV broadly neutralizing antibodies. |
|---|---|
| Authors: | Rodriguez LR; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Hall J; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Cardozo-Ojeda EF; Regeneron, White Plains, NJ., Lynch RM; Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington, DC., Perelson AS; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM., Schiffer JT; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA., Reeves DB; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2026 Jun 16. Date of Electronic Publication: 2026 Jun 16. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
